(Q39670640)

13 September 2017

title

Inhibition of human lung adenocarcinoma growth using survivint34a by low-dose systematic administration (English)

1 reference

13 September 2017

1 reference

Yan Shan

1

1 reference

13 September 2017

Chunting Wang

2

1 reference

13 September 2017

Li Yang

3

1 reference

13 September 2017

Li Juan Chen

4

1 reference

13 September 2017

Hong Xin Deng

5

1 reference

13 September 2017

Han Shuo Yang

6

1 reference

13 September 2017

Zhimian Li

7

1 reference

13 September 2017

Zhiyong Li

8

1 reference

13 September 2017

Li Pan

9

1 reference

13 September 2017

Fei Leng

10

1 reference

13 September 2017

Yuquan Wei

11

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20689177

17 June 2024

publication date

1 June 2010

1 reference

full work available at URL

13 September 2017

http://link.springer.com/content/pdf/10.1007/s12038-010-0025-3.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S12038-010-0025-3

http://link.springer.com/article/10.1007/s12038-010-0025-3/fulltext.html

17 June 2024

1 reference

https://api.crossref.org/works/10.1007/S12038-010-0025-3

http://link.springer.com/content/pdf/10.1007/s12038-010-0025-3

17 June 2024

1 reference

https://api.crossref.org/works/10.1007/S12038-010-0025-3

17 June 2024

published in

Journal of Biosciences

1 reference

13 September 2017

volume

35

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

209-216

1 reference

Control of apoptosis during angiogenesis by survivin expression in endothelial cells

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12038-010-0025-3

Cancer gene therapy using a survivin mutant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-010-0025-3

Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-010-0025-3

Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12038-010-0025-3

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin

21 January 2018

1 reference

12 December 2020

A p34(cdc2) survival checkpoint in cancer

1 reference

12 December 2020

Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells

1 reference

12 December 2020

Lentivirus-mediated gene therapy by suppressing survivin in BALB/c nude mice bearing oral squamous cell carcinoma

1 reference

12 December 2020

Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications.

1 reference

12 December 2020

A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy

1 reference

12 December 2020

Inhibition of melanoma tumor growth in vivo by survivin targeting

1 reference

12 December 2020

Dysregulation of apoptosis in cancer

1 reference

12 December 2020

Pro-apoptosis and anti-proliferation effects of a recombinant dominant-negative survivin-T34A in human cancer cells

1 reference

12 December 2020

Mechanisms of caspase activation and inhibition during apoptosis

1 reference

12 December 2020

Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice

1 reference

12 December 2020

Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma

1 reference

12 December 2020

Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant

1 reference

12 December 2020

Quantitatively determined survivin expression levels are of prognostic value in human gliomas

1 reference

12 December 2020

IAP family proteins--suppressors of apoptosis

1 reference

12 December 2020

Full-length dominant-negative survivin for cancer immunotherapy.

1 reference

12 December 2020

Survivin apoptosis: an interloper between cell death and cell proliferation in cancer.

1 reference

12 December 2020

Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway

1 reference

12 December 2020

The molecular basis and potential role of survivin in cancer diagnosis and therapy

1 reference

12 December 2020

Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement

1 reference

12 December 2020

Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma

1 reference

12 December 2020

Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis

1 reference

12 December 2020

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition

1 reference

12 December 2020

Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector

1 reference

12 December 2020

Nuclear survivin as a biomarker for non-small-cell lung cancer

1 reference

12 December 2020

Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administration

1 reference

12 December 2020

Prognostic importance of survivin in breast cancer

1 reference

12 December 2020

Apoptosis and disease: regulation and clinical relevance of programmed cell death

1 reference

12 December 2020

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

1 reference

12 December 2020

Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy

1 reference

12 December 2020

Survivin as a therapeutic target for radiation sensitization in lung cancer.

1 reference

12 December 2020

30

60

2805

A. Robert

2000

1 reference

https://api.crossref.org/works/10.1007/S12038-010-0025-3

Structural basis for phosphoserine-proline recognition by group IV WW domains

17 June 2024

36

1 reference

https://api.crossref.org/works/10.1007/S12038-010-0025-3

17 June 2024

Identifiers

1 reference

13 September 2017

1 reference